JP2010526106A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526106A5
JP2010526106A5 JP2010506709A JP2010506709A JP2010526106A5 JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5 JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5
Authority
JP
Japan
Prior art keywords
sulfonamido
dibenzo
furan
acid
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/062593 external-priority patent/WO2008137816A2/en
Publication of JP2010526106A publication Critical patent/JP2010526106A/ja
Publication of JP2010526106A5 publication Critical patent/JP2010526106A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506709A 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物 Withdrawn JP2010526106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92756307P 2007-05-04 2007-05-04
PCT/US2008/062593 WO2008137816A2 (en) 2007-05-04 2008-05-05 Tricyclic compounds as matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2010526106A JP2010526106A (ja) 2010-07-29
JP2010526106A5 true JP2010526106A5 (https=) 2012-05-17

Family

ID=39944224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506709A Withdrawn JP2010526106A (ja) 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物

Country Status (11)

Country Link
US (1) US20100227859A1 (https=)
EP (1) EP2144893A2 (https=)
JP (1) JP2010526106A (https=)
AR (1) AR066412A1 (https=)
CA (1) CA2685389A1 (https=)
CL (1) CL2008001257A1 (https=)
MX (1) MX2009011749A (https=)
PA (1) PA8779101A1 (https=)
PE (1) PE20090223A1 (https=)
TW (1) TW200900397A (https=)
WO (1) WO2008137816A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080098070A (ko) * 2006-02-22 2008-11-06 버텍스 파마슈티칼스 인코포레이티드 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘
WO2010091185A2 (en) * 2009-02-05 2010-08-12 Trustees Of Boston College Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
EP2417122A1 (en) * 2009-04-06 2012-02-15 PTC Therapeutics, Inc. Indole derivatives and methods for antiviral treatment
KR102159234B1 (ko) 2013-02-08 2020-09-23 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 레지스트 조성물, 레지스트 패턴 형성방법 및 이것에 이용하는 폴리페놀 유도체
EP2970312B1 (en) * 2013-03-11 2017-11-15 The Regents of The University of Michigan Bet bromodomain inhibitors and therapeutic methods using the same
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
KR20170099908A (ko) 2014-12-25 2017-09-01 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 화합물, 수지, 리소그래피용 하층막 형성 재료, 리소그래피용 하층막, 패턴 형성방법 및 정제방법
JP6766803B2 (ja) 2015-03-31 2020-10-14 三菱瓦斯化学株式会社 レジスト組成物、レジストパターン形成方法、及びそれに用いるポリフェノール化合物
JP6845991B2 (ja) * 2015-03-31 2021-03-24 三菱瓦斯化学株式会社 化合物、レジスト組成物及びそれを用いるレジストパターン形成方法
EP3346335A4 (en) 2015-08-31 2019-06-26 Mitsubishi Gas Chemical Company, Inc. MATERIAL FOR FORMING LITHOGRAPHY OF LAYER LAYERS, COMPOSITION FOR FORMING LITHOGRAPHY LAYER LAYERS, LITHOGRAPHY LAYERINGS AND METHOD FOR THE PRODUCTION THEREOF, PATTERN FORMULATION, RESIN AND CLEANING METHOD
WO2017038643A1 (ja) 2015-08-31 2017-03-09 三菱瓦斯化学株式会社 リソグラフィー用下層膜形成材料、リソグラフィー用下層膜形成用組成物、リソグラフィー用下層膜及びその製造方法、並びにレジストパターン形成方法
KR102687507B1 (ko) 2015-09-10 2024-07-24 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 화합물, 수지, 레지스트 조성물 또는 감방사선성 조성물, 레지스트 패턴 형성방법, 아몰퍼스막의 제조방법, 리소그래피용 하층막 형성재료, 리소그래피용 하층막 형성용 조성물, 회로패턴의 형성방법 및 정제방법
US10042251B2 (en) 2016-09-30 2018-08-07 Rohm And Haas Electronic Materials Llc Zwitterionic photo-destroyable quenchers
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
KR102435507B1 (ko) * 2019-07-31 2022-08-24 일동제약(주) 신규 벤조퓨란 유도체 및 이의 용도
CN113929645B (zh) * 2021-12-15 2022-03-11 长沙普济生物科技股份有限公司 一种光催化合成苯并呋喃基氨基酸表面活性剂的方法
CN117045635A (zh) * 2022-05-13 2023-11-14 中国海洋大学 一种3-苯基二苯并呋喃类化合物在药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
CA2378332A1 (en) * 1999-08-18 2001-02-22 Christopher Alan Conrad Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
MXPA01013172A (es) * 2001-02-14 2002-08-21 Warner Lambert Co Inhibidores sulfonamida de metaloproteinasa de matriz.
US20030157110A1 (en) * 2002-01-07 2003-08-21 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
JP2010507674A (ja) * 2006-10-27 2010-03-11 ワイス エルエルシー マトリクスメタロプロテアーゼ阻害剤としての三環式化合物

Similar Documents

Publication Publication Date Title
JP2010526106A5 (https=)
RU2013120064A (ru) Композиции и способы лечения глазного отека, неоваскуляризации и связанных с ними заболеваний
JP2017538750A5 (https=)
JP2007516173A5 (https=)
RU2491285C2 (ru) Органические соединения
RU2352568C2 (ru) [1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5
JP2006513258A5 (https=)
JP2009525984A5 (https=)
JP2010533158A5 (https=)
RU2009109147A (ru) Органические соединения
CA2656915A1 (en) Human protein tyrosine phosphatase inhibitors and methods of use
RU2011133833A (ru) Способы лечения синдрома сосудистой утечки
JP2005526815A5 (https=)
JP2006502134A5 (https=)
JP2008526866A5 (https=)
JP2013517279A5 (https=)
JP2015509510A5 (https=)
RU2017125520A (ru) Соединения, ингибирующие parg
RU2004127928A (ru) Производные морфолинилмочевины для использования в лечении воспалительных заболеваний
JP2010506825A5 (https=)
JP2013514308A5 (https=)
JP2007523905A5 (https=)
JP2006503009A5 (https=)
JP2009524677A5 (https=)
JP2008503497A5 (https=)